April 6, 2016 -
Suprema’s new BioStation L2 fingerprint terminal offers premium features and performance together with essential hardware to provide a comprehensive access control and time attendance solution.
According to a statement by the company, the BioStation L2 is a mid-range device that can support enterprise-level requirements in both access control and time attendance applications, and is enabled with the most powerful processor on the market today.
The new enhanced fingerprint algorithm reduces false rejection rates, even in conditions that are not ideal for fingerprint capture, and compensates for unsatisfactory fingerprint capture due to direct sunlight conditions or distorted finger images. BioStation L2 also features new live finger detection technology with improved algorithms and optical techniques that effectively eliminate possible fraud using various materials or fake fingers. The BioStation L2 can store and manage up to 500,000 users and 1 million logs.
“At Suprema, we are committed to continued innovation, based on the feedback and needs of our customers,” said James Lee, CEO of Suprema. “With the introduction of BioStation L2, we took customer feedback on every device currently offered, and channeled it into consideration for key elements of the device to bring a seamless convergence of performance and price.”
In February, Suprema announced the launch of BioSign, a fingerprint authentication solution for smartphones that is designed to support small sensors.